First gene therapy for prevalent pathologies in neurology receives FDA IND clearance - EG 427 initiating first-in-human clinical study

[Farooqji]

uk.finance.yahoo.com/news/f...

[park_bear]

"EG110A to start Phase 1b/2a clinical study in Neurogenic Detrusor Overactivity (NDO) patients

NDO is a severe bladder condition affecting millions of patients living with Spinal Cord Injury, Multiple Sclerosis, Parkinson’s disease and other neurological disorders

Other severe pathologies of the bladder to be investigated following this study

Preclinical data show EG110A’s potential for long-lasting efficacy on urinary continence and to address shortcomings of existing therapies"

[Boscoejean]

eg427.com/#

[Boscoejean]

not on clinical trials.gov yet

I went on there to try to find the locations for the trials

This is not a trial my husband would participate in however this information could be helpful